These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22027323)

  • 1. A Pan-European and Canadian prospective survey to evaluate patient satisfaction with the SoloSTAR insulin injection device in type 1 and type 2 diabetes.
    Hancu N; Czupryniak L; Genestin E; Sourij H
    J Diabetes Sci Technol; 2011 Sep; 5(5):1224-34. PubMed ID: 22027323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of patient satisfaction with a prefilled insulin injection device in patients with type 1 and type 2 diabetes.
    Siegmund T
    J Diabetes Sci Technol; 2011 Sep; 5(5):1235-7. PubMed ID: 22027324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose accuracy and injection force dynamics of a novel disposable insulin pen.
    Clarke A; Spollett G
    Expert Opin Drug Deliv; 2007 Mar; 4(2):165-74. PubMed ID: 17335413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosing accuracy with a novel pen device (SoloSTAR) as performed by patients with diabetes in a clinical setting.
    Hermanns N; Kulzer B; Haak T
    Diabetes Technol Ther; 2008 Aug; 10(4):322-7. PubMed ID: 18715206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a new reusable insulin pen (ClikSTAR) in Canadian patients with type 1 and type 2 diabetes mellitus receiving insulin glargine.
    Gottesman I; Perron P; Berard L; Stewart J; Basso N; Mettimano K; Elliott T
    Diabetes Technol Ther; 2012 Oct; 14(10):926-35. PubMed ID: 22775367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment for ease of use and preference of a new prefilled insulin pen (FlexTouch Degludec U100/U200) versus the SoloSTAR insulin pen by patients with diabetes and healthcare professionals.
    Pfützner A; Forst T; Niemeyer M; Bailey T
    Expert Opin Drug Deliv; 2014 Sep; 11(9):1381-9. PubMed ID: 24921223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usability, participant acceptance, and safety of a prefilled insulin injection device in a 3-month observational survey in everyday clinical practice in Australia.
    Carter J; Beilin J; Morton A; De Luise M
    J Diabetes Sci Technol; 2009 Nov; 3(6):1425-38. PubMed ID: 20144398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of a new disposable insulin pen and injection habits of diabetes patients in everyday clinical practice].
    Böhler S; Landgraf W; Schreiber SA
    MMW Fortschr Med; 2010 Jan; 151 Suppl 4():179-87. PubMed ID: 21595146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin glargine and glulisine SoloSTAR pens for the treatment of diabetes.
    Garg S; Kelly WC; Garg S
    Expert Rev Med Devices; 2008 Mar; 5(2):113-23. PubMed ID: 18331174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential Insulin Underdelivery from Prefilled and Reusable Insulin Pens in Cases of Premature Needle Withdrawal: A Laboratory Evaluation.
    Joubert M; Haddouche A; Morera J; Rod A; Reznik Y
    Diabetes Technol Ther; 2015 Oct; 17(10):712-6. PubMed ID: 26355757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of the SoloSTAR insulin pen device: design verification and validation.
    Bode A
    Expert Opin Drug Deliv; 2009 Jan; 6(1):103-12. PubMed ID: 19236211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin pen needles: effects of extra-thin wall needle technology on preference, confidence, and other patient ratings.
    Aronson R; Gibney MA; Oza K; Bérubé J; Kassler-Taub K; Hirsch L
    Clin Ther; 2013 Jul; 35(7):923-933.e4. PubMed ID: 23790553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of usability and patient preference for the new disposable insulin device Solostar versus Flexpen, lilly disposable pen, and a prototype pen: an open-label study.
    Haak T; Edelman S; Walter C; Lecointre B; Spollett G
    Clin Ther; 2007 Apr; 29(4):650-60. PubMed ID: 17617288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An analysis of patient acceptance and safety of a prefilled insulin injection device.
    Kroon L
    J Diabetes Sci Technol; 2009 Nov; 3(6):1439-41. PubMed ID: 20144399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Patient Satisfaction After Using Prefilled Insulin Pen in Real Life in Lithuania.
    Radzevičienė L; Apanavičienė DA
    J Diabetes Sci Technol; 2015 Jul; 9(4):939-40. PubMed ID: 25795640
    [No Abstract]   [Full Text] [Related]  

  • 16. Validation of the SoloSTAR insulin pen.
    Schwartz S; Vlajnic A
    Diabetes Technol Ther; 2008 Oct; 10(5):351-7. PubMed ID: 18715210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose accuracy comparison between SoloSTAR and FlexPen at three different dose levels.
    Penfornis A; Horvat K
    Diabetes Technol Ther; 2008 Oct; 10(5):359-62. PubMed ID: 18715211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin delivery with FlexPen: dose accuracy, patient preference and adherence.
    Pfützner A; Asakura T; Sommavilla B; Lee W
    Expert Opin Drug Deliv; 2008 Aug; 5(8):915-25. PubMed ID: 18713000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ease of Use of the Insulin Glargine 300 U/mL Pen Injector in Insulin-Naïve People With Type 2 Diabetes.
    Pohlmeier H; Berard L; Brulle-Wohlhueter C; Wu J; Dahmen R; Nowotny I; Klonoff D
    J Diabetes Sci Technol; 2017 Mar; 11(2):263-269. PubMed ID: 27664062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus.
    Korytkowski M; Bell D; Jacobsen C; Suwannasari R;
    Clin Ther; 2003 Nov; 25(11):2836-48. PubMed ID: 14693308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.